The Inflation Reduction Act (IRA) of 2022 empowered Medicare to negotiate prices for certain prescription drugs with high levels of Medicare spending. However, prices for new drugs cannot be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results